Kerr Douglas

SEC source: 0001814189-26-000005 · ownership.xml · nonDerivative · entry 2

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 162,564

F3 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $18.77 to $18.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.

F5 · balance_after: Includes 125,126 unvested RSUs.

SEC source: 0001814189-26-000005 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,854

F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on September 3, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $24.27 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.

SEC source: 0001814189-26-000004 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 167,599

F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on February 12, 2026. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.17 to $26.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.

F3 · balance_after: Includes 140,001 unvested RSUs.

SEC source: 0001814189-26-000002 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 169,155

F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $18.00 to $18.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.

F3 · balance_after: Includes 145,313 unvested RSUs.

SEC source: 0001193125-26-223966 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170,042

F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on February 12, 2026. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $18.20 to $18.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.

F3 · balance_after: Includes 148,313 unvested RSUs.

SEC source: 0001193125-26-096517 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 171,606

F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 153,625 unvested RSUs.

SEC source: 0001193125-26-055070 · ownership.xml · derivative · entry 2

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Common Stock · 130,000 shares

Expires 2036-02-11

F3 · derivative.exercise_date: This option was granted on February 12, 2026. The shares underlying the option are scheduled to vest over four years in equal monthly installments through February 12, 2030.

SEC source: 0001193125-26-055070 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,510

F1 · shares: Consists of shares of Common Stock issuable under 85,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on May 12, 2026.

F2 · balance_after: Includes 156,625 unvested RSUs.

SEC source: 0001193125-25-309641 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 87,510

F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $20.58 to $20.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.

F3 · balance_after: Includes 71,625 unvested RSUs.

SEC source: 0000950170-25-113538 · ownership.xml · nonDerivative · entry 2

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,390

F3 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F4 · balance_after: Includes 74,625 unvested RSUs.

SEC source: 0000950170-25-113538 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,263

F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on September 3, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $13.07 to $13.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.

SEC source: 0000950170-25-097006 · ownership.xml · derivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,110

Underlying: Common Stock · 65,110 shares

Expires 2035-07-15

F1 · derivative.exercise_date: This option was granted on July 16, 2025 (the "Grant Date"). The shares underlying the option are scheduled to vest over three years, with 50% of the shares underlying the grant vesting 18 months after the Grant Date and with the balance of the shares underlying the grant vesting in equal quarterly installments thereafter; provided that such option shall not be exercisable unless and until (i) the average closing price of the common stock on the Nasdaq Global Select Market over a 20 consecutive trading day period equals or exceeds $20.00 per share at any time during the three-year period following the Grant Date (the "Performance Period") or (ii) a Change in Control (as defined in the Issuer's Amended and Restated Executive Severance and Change in Control Benefits Plan) is consummated during the Performance Period pursuant to which a third party acquires the common stock for a price per share that the Board of Directors of the Issuer determines equals or exceeds $20.00 per share.

SEC source: 0000950170-25-083048 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,815

F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $13.21 to $13.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.

F3 · balance_after: Includes 89,500 unvested RSUs.

SEC source: 0000950170-25-035499 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,157

F1 · kind: Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 4, 2024. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $11.73 to $11.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.

F3 · balance_after: Includes 92,500 unvested RSUs.

SEC source: 0000950170-24-134073 · ownership.xml · derivative · entry 2

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,600

Underlying: Common Stock · 76,600 shares

Expires 2034-12-03

F3 · derivative.exercise_date: This option was granted on December 4, 2024. The shares underlying the option are scheduled to vest over four years in equal monthly installments through December 4, 2028.

SEC source: 0000950170-24-134073 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,500

F1 · shares: Consists of shares of Common Stock issuable under 48,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on March 4, 2025.

F2 · balance_after: Includes 95,500 unvested RSUs.

SEC source: 0000950170-24-103037 · ownership.xml · derivative · entry 2

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,300

Underlying: Common Stock · 150,300 shares

Expires 2034-09-02

F2 · derivative.exercise_date: This option was granted on September 3, 2024. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on September 3, 2025, and the remainder vesting in equal quarterly installments thereafter, subject to continuous service.

SEC source: 0000950170-24-103037 · ownership.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,500

F1 · shares: Consists of shares of Common Stock issuable under 47,500 restricted stock units ("RSU"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on September 3, 2025.

SEC source: 0001415889-24-002073 · form4-01312024_040102.xml · derivative · entry 3

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,021 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F2 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

F2 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

F3 · balance_after: Reflects the forfeit of 15,060 restricted stock units in connection with the reporting person's separation from the company.

SEC source: 0001415889-24-002073 · form4-01312024_040102.xml · nonDerivative · entry 2

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 385,628

SEC source: 0001415889-24-002073 · form4-01312024_040102.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 387,104

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock.

SEC source: 0001415889-24-001334 · form4-01172024_050126.xml · derivative · entry 6

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,081

Underlying: Common Stock · 6,694 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F4 · derivative.exercise_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

F4 · derivative.expiration_date: On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-24-001334 · form4-01172024_050126.xml · derivative · entry 5

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,437

Underlying: Common Stock · 7,437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F3 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

F3 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-24-001334 · form4-01172024_050126.xml · nonDerivative · entry 4

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 382,083

SEC source: 0001415889-24-001334 · form4-01172024_050126.xml · nonDerivative · entry 3

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 384,403

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock.

SEC source: 0001415889-24-001334 · form4-01172024_050126.xml · nonDerivative · entry 2

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 377,709

SEC source: 0001415889-24-001334 · form4-01172024_050126.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,286

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F2 · balance_after: Includes 2,445 shares acquired under the company's employee stock purchase plan since October 17, 2023.

SEC source: 0001415889-23-014357 · form4-10172023_061004.xml · derivative · entry 3

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,437

Underlying: Common Stock · 7,437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F2 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

F2 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-23-014357 · form4-10172023_061004.xml · nonDerivative · entry 2

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 370,404

SEC source: 0001415889-23-014357 · form4-10172023_061004.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 372,587

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock.

SEC source: 0001415889-23-011232 · form4-07182023_040701.xml · derivative · entry 3

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,874

Underlying: Common Stock · 7,437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F3 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

F3 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-23-011232 · form4-07182023_040701.xml · nonDerivative · entry 2

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,150

SEC source: 0001415889-23-011232 · form4-07182023_040701.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 367,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F2 · balance_after: Includes 3,116 shares acquired under the company's employee stock purchase plan since April 18, 2023.

SEC source: 0001415889-23-006595 · form4-04182023_080433.xml · derivative · entry 3

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,311

Underlying: Common Stock · 7,437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F2 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

F2 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-23-006595 · form4-04182023_080433.xml · nonDerivative · entry 2

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 356,780

SEC source: 0001415889-23-006595 · form4-04182023_080433.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 358,963

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock.

SEC source: 0001415889-23-001368 · form4-01242023_090127.xml · derivative · entry 2

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,775

Underlying: Common Stock · 26,775 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F3 · derivative.exercise_date: The shares underlying the restricted stock units vest over four years, with 25% of the shares vesting on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

F3 · derivative.expiration_date: The shares underlying the restricted stock units vest over four years, with 25% of the shares vesting on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-23-001368 · form4-01242023_090127.xml · derivative · entry 1

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,550

Underlying: Common Stock · 53,550 shares

Expires 2033-01-20

F1 · derivative.exercise_date: This option was granted on January 20, 2023. The shares underlying the option vest over four years, with 25% of the shares vesting on January 20, 2024 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-23-001072 · form4-01182023_090116.xml · derivative · entry 3

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,748

Underlying: Common Stock · 7,438 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F3 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

F3 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-23-001072 · form4-01182023_090116.xml · nonDerivative · entry 2

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,526

SEC source: 0001415889-23-001072 · form4-01182023_090116.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,104

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F2 · balance_after: Includes 1,865 shares acquired under the company's employee stock purchase plan since October 18, 2022.

SEC source: 0001415889-22-010645 · form4-10182022_011057.xml · derivative · entry 3

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,186

Underlying: Common Stock · 7,438 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F2 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

F2 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-22-010645 · form4-10182022_011057.xml · nonDerivative · entry 2

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,801

SEC source: 0001415889-22-010645 · form4-10182022_011057.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346,985

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock.

SEC source: 0001415889-22-007766 · form4-07192022_010736.xml · derivative · entry 3

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,624

Underlying: Common Stock · 14,876 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F3 · derivative.exercise_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

F3 · derivative.expiration_date: On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-22-007766 · form4-07192022_010736.xml · nonDerivative · entry 2

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,547

SEC source: 0001415889-22-007766 · form4-07192022_010736.xml · nonDerivative · entry 1

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F2 · balance_after: Includes 2,480 shares acquired under the company's employee stock purchase plan since July 8, 2021.

SEC source: 0001415889-22-000746 · form4-01252022_040102.xml · derivative · entry 2

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,500

Underlying: Common Stock · 59,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the company's common stock.

F3 · derivative.exercise_date: The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

F3 · derivative.expiration_date: The shares underlying the restricted stock units vest over two years, with 25% of the shares vesting on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-22-000746 · form4-01252022_040102.xml · derivative · entry 1

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,000

Underlying: Common Stock · 119,000 shares

Expires 2032-01-21

F1 · derivative.exercise_date: This option was granted on January 21, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on January 21, 2023 and the remaining shares vesting in equal quarterly installments thereafter.

SEC source: 0001415889-21-003583 · form4-07122021_010711.xml · derivative · entry 4

Kerr Douglas · CIK 0001814189 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,699

Underlying: Common Stock · 3,518 shares

Expires 2030-03-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2020.

F4 · derivative.exercise_date: The option to purchase 56,289 shares of common stock was granted on March 5, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on March 5, 2021 and the remaining shares vesting in equal quarterly installments thereafter.